Home›Companies›Biotech & Pharma›ARMR Sciences

ARMR Sciences Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 29, 2025·Suggest an edit

About ARMR Sciences

ARMR Sciences is a private company based in New York, New York, incorporated in 2023 in Delaware. It has reported $0 raised in one offering on Form D since August 2025. Its chief executive is Collin Gage.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetAug 29, 2025$0of $30.0M target0—EquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ARMR Sciences's Form D filed Aug 29, 2025.

SR
Shon Remich
Executive officer
JH
NJ
Nicholas Jacob
Executive officer
CG
Collin Gage
CEO and director
KK
Kenneth Kohn
Director
DS
Denise Shull
Director

Sources

  1. SECARMR Sciences Inc. filing history